# Clinical Trial in Patients With Metastatic Colorectal Cancer

> **NCT00081627** · PHASE2 · COMPLETED · sponsor: **Mast Therapeutics, Inc.** · enrollment: 48 (—)

## Conditions studied

- Colon Cancer
- Rectal Cancer

## Interventions

- **DRUG:** CoFactor and 5FU

## Key facts

- **NCT ID:** NCT00081627
- **Lead sponsor:** Mast Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 48 (—)
- **Last updated:** 2007-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081627, "Clinical Trial in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00081627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*